SCHEMBL5203028

SCHEMBL5203028

Nc1ncc(Oc2ccc(Cl)cc2)c(NC[C@H]2CC[C@@H](O)C2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK1 P51617 3/20 0.36
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35
KCNH2 Q12809 2/20 0.34
SCN9A Q15858 2/20 0.34
SCN5A Q14524 1/20 0.34
CCNT1 O60563 2/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
CDK9 P50750 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
PRKCQ Q04759 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TRPC6 Q9Y210 1/20 0.34
MAPT P10636 1/20 0.32
MCHR1 Q99705 1/20 0.32
POLB P06746 1/20 0.32
TTBK1 Q5TCY1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1376032 1.00 IRAK1 (0.36) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL1376037 1.00 IRAK1 (0.36) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL5203021 1.00 IRAK1 (0.36) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL1376035 1.00 IRAK1 (0.36) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL5205868 0.94 IRAK1 (0.38) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL5205876 0.94 IRAK1 (0.38) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL1378803 0.94 IRAK1 (0.38) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL1378800 0.94 IRAK1 (0.38) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL1378801 0.94 IRAK1 (0.38) IRAK1NOS3NOS1EGLN1KCNH2
SCHEMBL1378626 0.94 NOS3 (0.38) IRAK1NOS3NOS1EGLN1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed